Position in NTRA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$616,734
New position
Shares Held
2,272
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#499
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $4,469,091 across 9 Diagnostics & Research names. NTRA ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
5,353 | $941,217 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,412 | $707,920 | |
| 3 | NTRA |
Natera, Inc.
This page
|
2,272 | $616,734 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
910 | $481,926 | |
| 5 | DHR |
Danaher Corp /De/
|
2,381 | $453,532 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
728 | $383,248 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,854 | $379,096 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,566 | $302,582 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $616,734 | 2,272 | Shares | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||